Key facts
- Baker Brothers Investments is a hedge fund based in New York, New York with 3 tracked portfolio companies.
- Notable positions include ARTBIO, Aktis Oncology, Genesis Therapeutics.
- Baker Brothers Investments has 1 fund on record, raising $3.3B across the 1 that report a size.
- The team roster lists 1 person.
About Baker Brothers Investments
Founded in 2000
Registered with the SEC
Form ADV · 2026-03 · CRD 158149- Regulatory AUM
- —
- Private fund assets
- $28.1B
- Private funds
- 2 · 2 hedge
- Staff
- 60
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as BAKER BROS. ADVISORS LP).
Free account
See more of the book
- ·Watchlist + alerts for Baker Brothers Investments's activity
Create free account
No card required
Portfolio
3 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| ARTBIO | — | ▮ | ▮ | ▮ |
| Aktis Oncology | Drug Discovery | ▮ | ▮ | ▮ |
| Genesis Therapeutics | Drug Discovery | ▮ | ▮ | ▮ |
All 3 companies — valuations, dates and lead flags are a member feature | ||||
Funds
1 recorded- Baker Brothers Life Sciences LP2010$3.3B
$3.3B raised across the 1 fund that report a size
Team
1 people on record — 1 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Baker Brothers Investments invest in?
- Baker Brothers Investments has 3 recorded portfolio companies, including ARTBIO, Aktis Oncology, Genesis Therapeutics.